Back |
home / stock / nnvc / nnvc message board
Subject | By | Source | When |
---|---|---|---|
There is absolutely no similarity between what is | arvitar | investorshub | 02/10/2023 5:49:28 PM |
An interesting article out of Australia. Evolution | drkazmd65 | investorshub | 02/10/2023 3:03:21 PM |
I'm hoping that the other non-voting hold | arvitar | investorshub | 01/31/2023 8:26:57 PM |
I got yet another call from the proxy | drkazmd65 | investorshub | 01/23/2023 3:12:02 PM |
Good grief.... | arvitar | investorshub | 01/10/2023 10:40:41 PM |
Yeah - I'm not a particularly big fish | drkazmd65 | investorshub | 01/04/2023 5:41:52 PM |
Interesting. It's SOP for a company that needs | loanranger | investorshub | 01/04/2023 4:59:07 PM |
I actually got a call from the company | drkazmd65 | investorshub | 01/04/2023 3:27:59 PM |
Oh Boy!!!! Another conference announcement! | drkazmd65 | investorshub | 01/04/2023 2:17:15 PM |
Whoops! $NNVC's former auditor is an OTCMarkets Prohibited | loanranger | investorshub | 12/28/2022 1:44:50 AM |
$NNVC's auditor is an OTCMarkets Prohibited Service Provider. | loanranger | investorshub | 12/27/2022 9:53:47 PM |
Notice of Adjournment of Annual Meeting of Stockholders | loanranger | investorshub | 12/24/2022 10:41:57 PM |
I didn't see any of you folks at | loanranger | investorshub | 12/19/2022 5:55:59 PM |
And - that was a lot of nothing | arvitar | investorshub | 12/15/2022 2:31:33 AM |
The old day before announcement trick. | loanranger | investorshub | 12/14/2022 5:11:31 PM |
News, Short Squeeze, Breakout and More Instantly...
SHELTON, CT / ACCESSWIRE / July 11, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, discusses its development program for NV-387, a single drug that has shown activity against many respiratory viral infe...
SHELTON, CT / ACCESSWIRE / July 1, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, elaborates on its current assets and plans towards becoming a successful pharmaceutical company intending to revolutioni...
--News Direct-- NanoViricides CEO Dr Anil Diwan joined Steve Darling from Proactive to share promising news about the company's ultra-broad-spectrum antiviral, NV-387. The antiviral was found to be effective in protecting lungs from damage in a lethally infected Influenza A H3N2 mouse mod...